CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Data as of , from SEC Form 4 filings.
See up to 3 months of CRL. The 7-day demo opens the 1M and 3M ranges and puts CRL on your watchlist.
Start 7-day demoLatest CRL insider trades
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
The SEC lists CHARLES RIVER LABORATORIES INTERNATIONAL, INC. under CIK 0001100682, in commercial physical and biological research. We track it alongside the rest of the Health Care sector.
CRL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 10 | $3K |
| Open-market sale | 18 | 91,971 | $26.03M |
| Option exercise | 24 | 165,250 | |
CRL insider transactions (Form 4)
7190 Form 4 filings on record, the earliest from Nov 8, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Abraham Ceesay - Director | Grant or award | Common Stock | 946 | $135.04 | $128K | |
| Abraham Ceesay - Director | Grant or award | Stock Options (Right to Buy) | 2,082 | $135.04 | $281K | |
| Mark J. Enyedy - Director | Grant or award | Common Stock | 946 | $135.04 | $128K | |
| Mark J. Enyedy - Director | Grant or award | Stock Options (Right to Buy) | 2,082 | $135.04 | $281K | |
| Paul W. Graves - Director | Grant or award | Common Stock | 946 | $135.04 | $128K | |
| Paul W. Graves - Director | Grant or award | Stock Options (Right to Buy) | 2,082 | $135.04 | $281K | |
| Steven Barg - Director | Grant or award | Common Stock | 481 | $135.04 | $65K | |
| Steven Barg - Director | Grant or award | Common Stock | 946 | $135.04 | $128K | |
| Steven Barg - Director | Grant or award | Stock Options (Right to Buy) | 2,082 | $135.04 | $281K | |
| Flavia Pease - Officer | Grant or award | Common Stock | 7,152 | $135.63 | $970K | |
| Flavia Pease - Officer | Tax withholding / forfeiture | Common Stock | 185 | $135.63 | $25K | |
| Shannon M. Parisotto - Officer | Grant or award | Common Stock | 5,603 | $135.63 | $760K | |
| Shannon M. Parisotto - Officer | Tax withholding / forfeiture | Common Stock | 105 | $135.63 | $14K | |
| Joseph W. Laplume - Officer | Grant or award | Common Stock | 6,709 | $135.63 | $910K | |
| Joseph W. Laplume - Officer | Tax withholding / forfeiture | Common Stock | 155 | $135.63 | $21K | |
| Michael Gunnar Knell - Officer | Grant or award | Common Stock | 2,064 | $135.63 | $280K | |
| Michael Gunnar Knell - Officer | Tax withholding / forfeiture | Common Stock | 48 | $135.63 | $7K | |
| Michael Gunnar Knell - Officer | Tax withholding / forfeiture | Common Stock | 225 | $135.63 | $31K | |
| Birgit Girshick - Officer | Grant or award | Common Stock | 12,239 | $135.63 | $1.66M | |
| Birgit Girshick - Officer | Tax withholding / forfeiture | Common Stock | 283 | $135.63 | $38K | |
| Victoria L. Creamer - Officer | Grant or award | Common Stock | 6,252 | $135.63 | $848K | |
| Victoria L. Creamer - Officer | Tax withholding / forfeiture | Common Stock | 120 | $135.63 | $16K | |
| James C. Foster - Officer | Grant or award | Common Stock | 17,253 | $135.63 | $2.34M | |
| Flavia Pease - Officer | Tax withholding / forfeiture | Common Stock | 190 | $136.73 | $26K | |
| Flavia Pease - Officer | Tax withholding / forfeiture | Common Stock | 141 | $136.73 | $19K | |
| Shannon M. Parisotto - Officer | Tax withholding / forfeiture | Common Stock | 104 | $136.73 | $14K | |
| Shannon M. Parisotto - Officer | Tax withholding / forfeiture | Common Stock | 65 | $136.73 | $9K | |
| Shannon M. Parisotto - Officer | Tax withholding / forfeiture | Common Stock | 44 | $138.65 | $6K | |
| Joseph W. Laplume - Officer | Tax withholding / forfeiture | Common Stock | 161 | $136.73 | $22K | |
| Joseph W. Laplume - Officer | Tax withholding / forfeiture | Common Stock | 122 | $136.73 | $17K | |
| Joseph W. Laplume - Officer | Tax withholding / forfeiture | Common Stock | 83 | $138.65 | $12K | |
| Birgit Girshick - Officer | Tax withholding / forfeiture | Common Stock | 281 | $136.73 | $38K | |
| Birgit Girshick - Officer | Tax withholding / forfeiture | Common Stock | 242 | $136.73 | $33K | |
| Birgit Girshick - Officer | Tax withholding / forfeiture | Common Stock | 117 | $138.65 | $16K | |
| Michael Gunnar Knell - Officer | Tax withholding / forfeiture | Common Stock | 50 | $136.73 | $7K | |
| Michael Gunnar Knell - Officer | Tax withholding / forfeiture | Common Stock | 37 | $136.73 | $5K | |
| Michael Gunnar Knell - Officer | Tax withholding / forfeiture | Common Stock | 25 | $138.65 | $3K | |
| Victoria L. Creamer - Officer | Tax withholding / forfeiture | Common Stock | 123 | $136.73 | $17K | |
| Victoria L. Creamer - Officer | Tax withholding / forfeiture | Common Stock | 91 | $136.73 | $12K | |
| Victoria L. Creamer - Officer | Tax withholding / forfeiture | Common Stock | 62 | $138.65 | $9K | |
| Craig B. Thompson - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| Craig B. Thompson - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| George Llado Sr. - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| George Llado Sr. - Director | Grant or award | Common Stock | 519 | $134.98 | $70K | |
| George Llado Sr. - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| Martin Mackay - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| Martin Mackay - Director | Grant or award | Common Stock | 815 | $134.98 | $110K | |
| Martin Mackay - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| Reshema Kemps-Polanco - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| Reshema Kemps-Polanco - Director | Grant or award | Common Stock | 630 | $134.98 | $85K | |
| Reshema Kemps-Polanco - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| Virginia M. Wilson - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| Virginia M. Wilson - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| Nancy C. Andrews - Director | Grant or award | Common Stock | 946 | $134.98 | $128K | |
| Nancy C. Andrews - Director | Grant or award | Stock Options (Right to Buy) | 2,076 | $134.98 | $280K | |
| George Massaro - Director | Open-market sale | Common Stock | 35 | $136.32 | $5K | |
| George Massaro - Director | Open-market sale | Common Stock | 81 | $137.68 | $11K | |
| George Massaro - Director | Open-market sale | Common Stock | 24 | $139.05 | $3K | |
| George Massaro - Director | Open-market sale | Common Stock | 91 | $139.95 | $13K | |
| George Massaro - Director | Open-market sale | Common Stock | 21 | $140.78 | $3K | |
| George Massaro - Director | Open-market sale | Common Stock | 14 | $141.85 | $2K | |
| George Massaro - Director | Open-market sale | Common Stock | 7 | $143.77 | $1K | |
| George Massaro - Director | Open-market sale | Common Stock | 7 | $145.54 | $1K | |
| Joseph W. Laplume - Officer | Open-market sale | Common Stock | 500 | $145.41 | $73K | |
| Flavia Pease - Officer | Tax withholding / forfeiture | Common Stock | 889 | $116.89 | $104K | |
| James C. Foster - Officer | Gift | Common Stock | 4,500 | $0.00 | - | |
| Richard F. Wallman - Director | Gift | Common Stock | 4,540 | $0.00 | - | |
| Richard F. Wallman - Director | Open-market sale | Common Stock | 3,371 | $215.75 | $727K | |
| Richard F. Wallman - Director | Open-market sale | Common Stock | 3,250 | $216.50 | $704K | |
| Richard F. Wallman - Director | Open-market sale | Common Stock | 1,000 | $216.50 | $217K | |
| William D. Barbo - Officer | Gift | Common Stock | 470 | $0.00 | - |
Item 7.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07, 9.01
Item 2.02, 9.01
Recent CRL Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Parisotto Shannon M | Officer | 981 | $309K | View on EDGAR | |
| FOSTER JAMES C | Director | 33,561 |
CRL insider trading FAQ
What is the latest insider trade for CRL?
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had 13 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for CRL runs to 90 Form 4 filings, the earliest from 2024-11-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CRL stock?
1 insider purchase of CRL was filed in the last 90 days, totaling $3K.
How many insiders are selling CRL stock?
18 insider sales of CRL were filed in the last 90 days, totaling $26.03M.
Where can I see CRL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CRL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Shannon M. Parisotto view on EDGAR
- - Glenn Coleman view on EDGAR
- - James C. Foster view on EDGAR
- - Birgit Girshick view on EDGAR
- - Shannon M. Parisotto view on EDGAR
- - Nancy C. Andrews view on EDGAR
- - Birgit Girshick view on EDGAR
- - Shannon M. Parisotto view on EDGAR
- - Joseph W. Laplume view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CRL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CRL with a 7-day demo
- CRL on your watchlist
- Every CRL Form 4 filing on record
- Up to 3 months of CRL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
